The impact of rotavirus on the world’s children

NewsGuard 100/100 Score

Event: Experts convened at the 6th International Rotavirus Symposium will be available for comment. With vaccines against the killer disease of rotavirus almost in hand, government representatives, scientists, public health professionals and vaccine industry representatives will be convened in Mexico City to review progress toward safe, effective rotavirus vaccines and address the question of how to make sure they get to the world’s poorest children.

When: Wednesday, July 7, 2004, 11-11:30 am.

Where: Presidente Intercontinental Hotel
Campos Eliseos 218, Polanco Zone
Phone +52 (55) 53277700
Mexico City, Mexico.

Who:

  • Dr. Ciro de Quadros, Sabin Vaccine Institute
  • Dr. Roger Glass, Centers for Disease Control and Prevention
  • Dr. Julio Frenk, Secretary of Health, Mexico
  • Dr. Jon Andrus, Pan American Health Organization
  • Dr. Roberto Tapia, Vice Secretary of Health, Mexico
  • Dr. Ruth Bishop, University of Melbourne, discoverer of rotavirus
  • Dr. Albert Kapikian, Nat’l Inst. of Allergy and Infectious Diseases, rotavirus vaccine inventor.

Note: Journalists wishing to attend the symposium closing luncheon briefing at noon on Friday, July 9 are advised to register at the conference press room or with one of the contacts below.

Health experts are preparing for a pivotal meeting in Mexico City July 7, where they will discuss the latest information about rotavirus, a deadly disease that kills half a million children each year, and review the status of vaccines against it.

The most common cause of severe diarrhea, hospitalizations, and deaths among children worldwide, rotavirus is a high priority for developing countries with limited health services, where 85 percent of the 500,000 deaths occur, most from severe dehydration. Vaccines currently under development could be introduced into the routine program of childhood immunizations within 1-3 years and could prevent this most common cause of severe morbidity and mortality in children. The international community has recognized the accelerated development and introduction of rotavirus vaccines as a high priority.

Experts including Dr. Jon Andrus of the Pan American Health Organization (PAHO), Dr. Ruth Bishop, discoverer of rotavirus, Dr. Roger Glass of the U. S. Centers for Disease Control (CDC), Dr. Albert Kapikian, inventor of the rotavirus vaccine, Dr. Roberto Tapia Conyer of the Mexico Ministry of Health, and Dr. Ciro de Quadros of the Sabin Vaccine Institute, who led the successful polio eradication effort in the Americas, will gather in Mexico July 7-9 to discuss all aspects of rotavirus and rotavirus vaccines. Also present will be leading scientists and health ministers from throughout Central and South America; vaccine industry representatives involved in rotavirus vaccine development; and experts from leading public health and donor organizations, including the World Health Organization (WHO), the Global Alliance for Vaccines and Immunization, and the Rotavirus Vaccine Program.

New data on the extent and burden of the virus in developing countries, and insights into its biology and pathology will also be reported at the symposium on rotavirus, being held at the Presidente Intercontinental Hotel, Campos Eliseos 218, Polanco, in Mexico City. Topics of the main sessions include epidemiology and disease burden of rotavirus, its virology, pathogenesis and immunity, past experience and results with new rotavirus vaccines, the health economic and financing of the vaccines and a roundtable on perspectives in vaccine introduction.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study links pneumonia transmission in seniors to contact with young children